Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer von Xiang, Hong, Chan, Abigael G., Ahene, Ago, Bellovin, David I., Deng, Rong, Hsu, Amy W., Jeffry, Ursula, Palencia, Servando, Powers, Janine, Zanghi, James, Collins, Helen

Volltext

PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing Malignancies von Sheng, Qing, D'Alessio, Joseph A., Menezes, Daniel L., Karim, Christopher, Tang, Yan, Tam, Angela, Clark, Suzanna, Ying, Chi, Connor, Anu, Mansfield, Keith G., Rondeau, Jean-Michel, Ghoddusi, Majid, Geyer, Felipe C., Gu, Jane, McLaughlin, Margaret E., Newcombe, Rick, Elliot, GiNell, Tschantz, William R., Lehmann, Sylvie, Fanton, Christie P., Miller, Kathy, Huber, Thomas, Rendahl, Katherine G., Jeffry, Ursula, Pryer, Nancy K., Lees, Emma, Kwon, Paul, Abraham, Judith A., Damiano, Jason S., Abrams, Tinya J.

Volltext

Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer von HENSHALL, Susan M, AFAR, Daniel E. H, QUINN, David I, TURNER, Jennifer J, DELPRADO, Warick, LEE, C-Soon, GOLOVSKY, David, BRENNER, Phillip C, O'NEILL, Gordon F, KOONER, Raji, STRICKER, Phillip D, GRYGIEL, John J, RASIAH, Krishan K, MACK, David H, SUTHERLAND, Robert L, HORVATH, Lisa G, GISH, Kurt, CARAS, Ingrid, RAMAKRISHNAN, Vanitha, WONG, Melanie, JEFFRY, Ursula, KENCH, James G

Volltext

Abstract 3629: BLZ945, a selective c-fms (CSF-1R) kinase inhibitor for the suppression of tumor-induced osteolytic lesions in bone von Wiesmann, Marion, Daniel, Dylan L., Pryer, Nancy, Sutton, James, Sung, Victoria, Wang, Tao, Jeffry, Ursula, Oei, Yoko, Kaufman, Susan, Lenahan, William, Lee, Isabelle, Huh, Kay, Sim, Janet

Volltext

Induction of TCR Gene Rearrangements in Uncommitted Stem Cells by a Subset of IL-7 Producing, MHC Class II–Expressing Thymic Stromal Cells von Oosterwegel, Mariëtte A, Haks, Marille C, Jeffry, Ursula, Murray, Richard, Kruisbeek, Ada M

Volltext

NK1.1+ T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production von Vicari, Alain P., Herbelin, André, Leite-de-Moraeas, Maria do Carmo, Freeden-Jeffry, Ursula Von, Murray, Richard, Zlotnik, Albert

Volltext

Uniform overexpression and rapid accessibility of α5β1 integrin on blood vessels in tumors von PARSONS-WINGERTER, Patricia, KASMAN, Lan M, MCDONALD, Donald M, NORBERG, Scott, MAGNUSSEN, Anette, ZANIVAN, Sara, RISSONE, Alberto, BALUK, Peter, FAVRE, Cecile J, JEFFRY, Ursula, MURRAY, Richard

Volltext

Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice von Akashi, K, Kondo, M, von Freeden-Jeffry, U, Murray, R, Weissman, I L

Volltext

Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine von von Freeden-Jeffry, U, Vieira, P, Lucian, L A, McNeil, T, Burdach, S E, Murray, R

Volltext

The Earliest T Lineage–Committed Cells Depend on IL-7 for Bcl-2 Expression and Normal Cell Cycle Progression von von Freeden-Jeffry, Ursula, Solvason, Nanette, Howard, Maureen, Murray, Richard

Volltext

Abstract DDT02-02: Preclinical development of LFA102, a highly potent and selective neutralizing antibody against the prolactin receptor von Damiano, Jason, Rendahl, Katherine, Karim, Christopher, Jeffry, Ursula, Wasserman, Ernesto, Holash, Jocelyn, Rediske, John, Kakar, Shefali, Fanidi, Abdallah, Fang, Eric, Aziz, Natasha, Sim, Janet, Gardner, Humphrey, Luqman, Mohammad, Mirza, Amer, Handa, Masahisa, Neben, Tamara, Beddinger, Daniel, Abraham, Judith

Volltext

E-selectin up-regulation allows for targeted drug delivery in prostate cancer von BHASKAR, Vinay, LAW, Debbie A, PONG, Melody, POWERS, Rick, SENTER, Peter, STOCKETT, David, SUTHERLAND, Robert L, VON FREEDEN-JEFFRY, Ursula, WILLHITE, Dorian, MURRAY, Richard, AFAR, Daniel E. H, RAMAKRISHNAN, Vanitha, IBSEN, Eric, BREINBERG, Danna, CASS, Kellie M, DUBRIDGE, Robert B, EVANGELISTA, Ferdinand, HENSHALL, Susan M, HEVEZI, Peter, MILLER, Jennifer C

Volltext

Methods of treatment with CD80 extracellular domain polypeptides von Sennino, Barbara, Brennan, Thomas, Barbee, Susannah D, Jeffry, Ursula

Volltext bestellen

Immunological Profile and Safety Evaluation in a 23-Week Single Dose Study in Cynomolgus Monkey with CHIR-12.12, a Fully Human Antagonist Anti-CD40 Antibody von Jeffry, Ursula B., Luqman, Mohammad, Huh, Kay, Klinger, Julie, Frings, Werner, Turner, Nancy

Volltext

IL-7 Deficiency Prevents Development of a Non-T Cell Non-B Cell-Mediated Colitis von von Freeden-Jeffry, Ursula, Davidson, Natalie, Wiler, Rhonda, Fort, Madeline, Burdach, Stefan, Murray, Richard

Volltext

Safety Evaluation of an Fully Human Antagonist Anti-CD40 Antibody, CHIR-12.12, in a Dose Range-Finding Study in Cynomolgus Monkeys von Jeffry, Ursula B., Huh, Kay, Tong, Xia, Klinger, Julie, Frings, Werner, Fuchs, Antje, Turner, Nancy, Luqman, Mohammad

Volltext

Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors von Parsons-Wingerter, Patricia, Kasman, Ian M, Norberg, Scott, Magnussen, Anette, Zanivan, Sara, Rissone, Alberto, Baluk, Peter, Favre, Cecile J, Jeffry, Ursula, Murray, Richard, McDonald, Donald M

Volltext

CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES FOR USE IN INCREASING CENTRAL MEMORY T CELLS von JEFFRY, Ursula, SENNINO, Barbara, BRENNAN, Thomas, BARBEE, Susannah D

Volltext bestellen

Uniform Overexpression and Rapid Accessibility of α 5β 1 Integrin on Blood Vessels in Tumors von Parsons-Wingerter, Patricia, Kasman, Ian M., Norberg, Scott, Magnussen, Anette, Zanivan, Sara, Rissone, Alberto, Baluk, Peter, Favre, Cecile J., Jeffry, Ursula, Murray, Richard, McDonald, Donald M.

Volltext

METHODS OF TREATMENT WITH CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES von JEFFRY, Ursula, SENNINO, Barbara, BRENNAN, Thomas, BARBEE, Susannah D

Volltext bestellen